BIOENG 2151 - MEDICAL PRODUCT DEVELOPMENT

Minimum Credits: 3
Maximum Credits: 3
A didactic course that uses principles of system engineering, the stage-gate process for medical product development and engineering and business analysis principles to evaluate the commercial potential proposed medical devices to further develop feasible solutions to a clinical problem identified in BIOENG 2150. Students will demonstrate use of systems engineering techniques to prioritize a set of feasible device and/or system solutions and ability to use intellectual property (IP) tools to determine suitability for further development. Students will demonstrate use of course principles in development of a commercialization plan for a proposed medical product. Design controls required by fad and international bodies; systems engineering methodologies; intellectual property (IP) and IP search tools; brief market analysis; size by region, growth, competition, barriers to entry, sustainable advantage; reimbursement issues for proposed medical device/system; basic financial analysis ’ students will construct spreadsheets typically presented to senior business management. This will include estimates of costs, margins, break-even analysis, NPV, hurdle rates, ROI, IRR; codes, standards, and regulatory processes (FDA, IEC & ISO, UL, ministry of health (Japan), NRC, BRH, notified bodies, obtaining broad indications for use); safety, reliability, product liability considerations, manufacturability considerations (DFM ’ design for manufacture, workflows)
Academic Career: Graduate
Course Component: Lecture
Grade Component: Grad Letter Grade
Course Requirements: PREQ: BIOENG 2150; PROG: Swanson School of Engineering

Click here for class schedule information.

Add to Portfolio(opens a new window)